VALENTE, SERAFINA
 Distribuzione geografica
Continente #
NA - Nord America 11.567
EU - Europa 9.312
AS - Asia 6.083
SA - Sud America 1.463
AF - Africa 409
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 28.853
Nazione #
US - Stati Uniti d'America 11.340
IT - Italia 3.039
RU - Federazione Russa 2.410
SG - Singapore 2.019
CN - Cina 1.442
BR - Brasile 1.215
IE - Irlanda 840
VN - Vietnam 818
GB - Regno Unito 752
HK - Hong Kong 553
DE - Germania 529
FR - Francia 432
KR - Corea 380
FI - Finlandia 338
SE - Svezia 305
IN - India 242
ZA - Sudafrica 217
NL - Olanda 202
CA - Canada 114
BD - Bangladesh 92
ES - Italia 85
MX - Messico 79
AR - Argentina 78
PL - Polonia 70
IQ - Iraq 64
JP - Giappone 62
UA - Ucraina 58
ID - Indonesia 57
AT - Austria 55
EC - Ecuador 46
TR - Turchia 44
KE - Kenya 42
CI - Costa d'Avorio 37
CZ - Repubblica Ceca 37
IR - Iran 35
VE - Venezuela 34
PK - Pakistan 32
CH - Svizzera 31
UZ - Uzbekistan 31
PH - Filippine 30
SA - Arabia Saudita 28
MA - Marocco 27
CL - Cile 23
CO - Colombia 22
EG - Egitto 19
PE - Perù 19
LT - Lituania 18
MY - Malesia 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
NG - Nigeria 17
AL - Albania 16
BE - Belgio 16
DZ - Algeria 14
AZ - Azerbaigian 13
JO - Giordania 13
TN - Tunisia 13
NP - Nepal 11
AU - Australia 9
BG - Bulgaria 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
KZ - Kazakistan 8
CY - Cipro 7
IL - Israele 7
LV - Lettonia 7
TW - Taiwan 7
MK - Macedonia 6
QA - Qatar 6
TH - Thailandia 6
UY - Uruguay 6
EE - Estonia 5
ET - Etiopia 5
EU - Europa 5
JM - Giamaica 5
KG - Kirghizistan 5
NO - Norvegia 5
OM - Oman 5
PA - Panama 5
RO - Romania 5
AO - Angola 4
BB - Barbados 4
BY - Bielorussia 4
GE - Georgia 4
GR - Grecia 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BH - Bahrain 3
BW - Botswana 3
HN - Honduras 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
XK - ???statistics.table.value.countryCode.XK??? 3
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
GA - Gabon 2
Totale 28.815
Città #
Dallas 6.187
Singapore 1.261
Dublin 799
Moscow 757
Ashburn 565
Hefei 556
Hong Kong 518
Southend 508
Santa Clara 450
San Jose 439
Milan 438
Seoul 377
Chandler 311
Siena 307
Munich 278
Ho Chi Minh City 277
Beijing 268
Council Bluffs 263
Los Angeles 255
Helsinki 215
Rome 211
Johannesburg 199
Florence 198
New York 182
Fairfield 178
Lauterbourg 177
Hanoi 175
The Dalles 139
São Paulo 125
Princeton 95
Houston 94
Bengaluru 84
Buffalo 84
Seattle 80
Nuremberg 75
Chicago 73
Woodbridge 69
Orem 68
Shanghai 68
Cambridge 63
Ann Arbor 59
Redondo Beach 57
Turku 57
Wilmington 57
Bologna 55
Tokyo 54
Warsaw 54
Lappeenranta 53
London 52
Naples 49
Frankfurt am Main 48
Rio de Janeiro 47
Dong Ket 43
Guangzhou 39
Montreal 38
Abidjan 37
Brescia 37
Haiphong 37
Toronto 37
Denver 35
Málaga 35
Baghdad 32
Turin 32
Brooklyn 31
Chennai 31
Poplar 31
Amsterdam 28
Da Nang 28
Fremont 28
San Diego 28
Stockholm 28
Mexico City 27
Tashkent 27
Boardman 26
Mumbai 26
Piscataway 25
Portsmouth 25
Vienna 24
Atlanta 23
Boston 22
Düsseldorf 22
Manchester 22
Phoenix 22
San Mateo 22
Biên Hòa 21
Salt Lake City 21
Washington 20
Zurich 20
Brasília 19
Brno 18
Guarulhos 18
Padova 18
Paris 18
Porto Alegre 18
Salvador 18
Curitiba 17
Dhaka 17
Genoa 17
Guayaquil 17
Hải Dương 17
Totale 19.350
Nome #
Vo2peak, Ve/VCO2, and Cardiac Remodeling Correlate with Long-Term Cardiovascular Outcome in Heart Failure Patients 1.266
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect in Athletes: A Study With a Long-Term Follow-Up 790
Antiplatelet and Anticoagulation Therapy in Athletes: A Cautious Compromise… If Possible! 635
A first update on mapping the human genetic architecture of COVID-19 575
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 574
Il test da sforzo cardiopolmonare: uno strumento fondamentale per una prescrizione personalizzata dell’esercizio fisico nei pazienti con malattia cardiovascolare : Cardiopulmonary exercise testing: an essential tool for a tailored exercise prescription in patients with cardiac disease 522
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 505
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 499
Prognostic value of left atrial strain in acute and chronic heart failure: A meta-analysis 436
Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction 427
Pressure-strain loops unveil haemodynamics behind mechanical circulatory support systems 411
Genetic mechanisms of critical illness in COVID-19 409
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 387
An explainable model of host genetic interactions linked to COVID-19 severity 365
Antirheumatic agents in covid-19: is IL-6 the right target? 353
The loss of left atrial contractile function predicts a worse outcome in HFrEF patients 352
The role of cardiac computed tomography in sports cardiology: back to the future! 327
Pathogen-sugar interactions revealed by universal saturation transfer analysis 323
null 320
Peripheral biomarkers' panel for severe COVID-19 patients 316
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 311
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 292
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 283
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 272
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 271
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 253
Serial KL-6 measurements in COVID-19 patients 245
Prognostic bioindicators in severe COVID-19 patients 244
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 242
Left atrial strain by speckle tracking predicts atrial fibrosis in patients undergoing heart transplantation 239
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 234
Clinician approach to cardiopulmonary exercise testing for exercise prescription in patients at risk of and with cardiovascular disease 229
The importance of ventilatory thresholds to define aerobic exercise intensity in cardiac patients and healthy subjects 229
A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play 227
Ablation therapy for ventricular arrhythmias in patients with LVAD: Multiple faces of an electrophysiological challenge 222
Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: Sudden cardiac death in the young 221
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 219
A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide 217
Right ventricular dysfunction in left ventricular assist device candidates: is it time to change our prospective? 214
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 213
SARS-CoV-2 in pleural fluid in a kidney transplant patient 213
Bedside Ultrasound for Hemodynamic Monitoring in Cardiac Intensive Care Unit 205
Detection of cardiac allograft vasculopathy by multi-layer left ventricular longitudinal strain in heart transplant recipients 204
ACUTE HF score: a new multi-parametric score for the prognostication of acute heart failure 201
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients 199
Whole-genome sequencing reveals host factors underlying critical COVID-19 198
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol 198
Clinical, echocardiographic and hemodynamic predictors of right heart failure after LVAD placement 198
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 196
Cardiogenic shock and acute kidney injury: the rule rather than the exception 193
Aortic root/left ventricular diameters golden ratio in competitive athletes 192
Clinical management of young competitive athletes with premature ventricular beats: A prospective cohort study 192
Clinical and molecular characterization of COVID-19 hospitalized patients 191
Survival in acute heart failure in intensive cardiac care unit: a prospective study 191
ADONHERS (Aged DONor HEart Rescue by Stress Echo) National Protocol: Recipient's Survival after 10-Year Follow-Up 190
Basic and advanced echocardiography in advanced heart failure: an overview 189
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 189
Right ventricular myocardial work for the prediction of early right heart failure and long-term mortality after left ventricular assist device implant 179
Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation 176
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 174
Left ventricular fibrosis as a main determinant of filling pressures and left atrial function in advanced heart failure 171
SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed? 171
Cardiopulmonary Fitness and Personalized Exercise Prescription in Patients With Hypertrophic Cardiomyopathy 167
How to evaluate resting ECG and imaging in children practising sport: a critical review and proposal of an algorithm for ECG interpretation 167
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab 167
Correlation of Left Ventricular Myocardial Work Indices with Invasive Measurement of Stroke Work in Patients with Advanced Heart Failure 166
Heart transplantation and anti-HLA antibodY: myocardial dysfunction and prognosis - HeartLAy study 165
Tricuspid Regurgitation Velocity and Mean Pressure Gradient for the Prediction of Pulmonary Hypertension According to the New Hemodynamic Definition 155
Echocardiography for left ventricular assist device implantation and evaluation: an indispensable tool 153
Diastolic function in heart transplant: From physiology to echocardiographic assessment and prognosis 153
Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical Outcome 152
COVID-19 and the burning issue of drug interaction: Never forget the ECG 151
Left ventricular assist device in cardiac amyloidosis: friend or foe? 150
Left ventricular assist device and transcatheter edge-to-edge mitral valve repair in advanced heart failure: allies or enemies? 148
Safe performance of echocardiography during the COVID-19 pandemic: A practical guide 148
Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning 146
Risk stratification in cardiogenic shock: a focus on the available evidence 145
Post-acute sequelae of COVID-19: the potential role of exercise therapy in treating patients and athletes returning to play 144
Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value 144
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences 144
Zero-fluoroscopy catheter ablation of premature ventricular contractions at left coronary cusp near left main coronary artery 141
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 141
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications 139
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 136
Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients 135
ANMCO Position Paper: Amyloidosis for the clinical cardiologist. A "clinical primer" from the ANMCO Rare Disease Working Group [Position paper ANMCO: L’amiloidosi per il cardiologo clinico. Un “clinical primer” dell’Area Malattie Rare ANMCO] 134
Hemodynamic variations and pitfalls during venoarterial extracorporeal membrane oxygenation and left ventricular apical unloading as bridge to heart transplantation 133
Case Report: Two Case Reports of Acute Myopericarditis After mRNA COVID-19 Vaccine 132
Acute coronary syndromes during COVID-19 131
ANMCO Position Paper: Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation 129
From Coronary Artery Ectasia to Giant Coronary Artery Aneurysm: Is it Necessary to Follow-Up? 123
The acute effects of an ultramarathon on atrial function and supraventricular arrhythmias in master athletes 122
Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence 122
Insight into Atrial Fibrillation in LVAD Patients: From Clinical Implications to Prognosis 122
ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes 121
ANMCO Position paper: Antithrombotic treatment of patients with atrial fibrillation and acute or chronic coronary syndromes undergoing coronary angioplasty with stent implantation [Position paper ANMCO: Trattamento antitrombotico nei pazienti con fibrillazione atriale e sindromi coronariche acute o croniche sottoposti ad angioplastica coronarica con impianto di stent] 121
ANMCO Position Paper: Cardiovascular disease in women - Prevention, diagnosis, treatment and organization of care ANMCO Position Paper: Cardiovascular disease in women - Prevention, diagnosis, treatment and organization of care 119
Myocardial Work Indices Predict Hospitalization in Patients with Advanced Heart Failure 118
COVID-19 in patients with heart failure: the new and the old epidemic 118
Clinical pathway for cardiogenic shock. A proposal from ANMCO Tuscany [Clinical pathway per lo shock cardiogeno. La proposta dell’ANMCO Toscana] 116
Totale 24.197
Categoria #
all - tutte 81.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021264 0 0 0 0 0 0 0 0 0 58 113 93
2021/20221.223 102 96 72 68 64 81 122 80 57 103 144 234
2022/20231.517 88 139 178 136 98 220 130 137 92 83 88 128
2023/20242.045 93 88 204 172 104 363 561 96 40 79 67 178
2024/20255.896 167 188 468 265 499 687 531 366 516 312 543 1.354
2025/202617.888 924 4.187 3.860 2.069 2.799 582 1.553 478 600 836 0 0
Totale 29.596